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EXPERIMENTAL DESIGN & 
METHODS
The Impact of Diabetic Conditions and AGE/RAGE Signaling on Cardiac 
Fibroblast Migration
Stephanie D. Burr*, Mallory B. Harmon, and James A. Stewart, Jr.




Diabetic individuals have an increased risk for developing cardiovascular
disease due to stiffening of the left ventricle, which is thought to occur, in
part, by increased AGE/RAGE signaling inducing fibroblast
differentiation. Advanced glycation end products (AGEs) accumulate
within the body over time, and under hyperglycemic conditions, the
formation and accumulation of AGEs is accelerated. AGEs exert their
effect by binding to their receptor (RAGE) and can induce myofibroblast
differentiation, leading to increased cell migration. Previous studies have
focused on fibroblast migration during wound healing, in which diabetics
have impaired fibroblast migration compared to healthy individuals.
However, the impact of diabetic conditions as well as AGE/RAGE
signaling has not been extensively studied in cardiac fibroblasts.
Therefore, the goal of this study was to determine how the AGE/RAGE
signaling pathway impacts cell migration in non-diabetic and diabetic
cardiac fibroblasts. Cardiac fibroblasts were isolated from non-diabetic
and diabetic mice with and without functional RAGE and used to perform
a migration assay. Cardiac fibroblasts were plated on plastic, non-
diabetic, or diabetic collagen, and when confluency was reached, a line
of migration was generated by scratching the plate and followed by
treatment with pharmacological agents that modify AGE/RAGE signaling.
Diabetic fibroblasts displayed an increase in migration compared to non-
diabetic fibroblasts whereas inhibiting the AGE/RAGE signaling pathway
resulted in a significant increase in migration. The results indicate that
the AGE/RAGE signaling cascade causes a decrease in cardiac
fibroblast migration and altering the pathway will produce alterations in
cardiac fibroblast migration.
HYPOTHESIS
Mice: Diabetic mice (db) are 
homozygous for leptin receptor 
mutation, non-diabetic mice 
(non-db) are heterozygous. 
Transgenic mice lacking an 
active form of RAGE (non-db
RKO) were used as well as 
Rap1a knockout mice and their 
control, Rap1a WT.
Fibroblast Isolation: Cardiac 
fibroblasts were isolated (2-3 
mice per isolation) and 
maintained in DMEM containing 
15% FBS. 
Collagen Isolation: Collagen 
was isolated from tails of 
diabetic or non-diabetic mice.
Drug Treatment: AGE-BSA
(glycated albumin 0.5mg/ml), ), 
U0126 (5µm; inhibitor of ERK), 
and PKC-ζ Pseudosubstrate
(1µg/mL; ps-PKC-ζ).
Activation of the RAGE cascade alters cardiac fibroblast migration in type II 
diabetic mice.
DISCUSSION
Table 1: Morphological data for mice used for in vitro experiments. 
Data represents an n-value of 7-12 isolations. One-way ANOVA followed 




•AGE/RAGE signaling modified 
cardiac fibroblast migration
•None/Low levels of RAGE 
signaling resulted in high levels 
of migration
• “Normal” levels of RAGE 
signaling resulted in the lowest 
amount of fibroblast migration
•High (above normal) levels of 
RAGE signaling induced 
increase migration which may 
be a result of increased 
fibroblast “activation”
•Rap1a is involved in fibroblast 
migration in conjunction with 
RAGE signaling
*mic drop*
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DEPARTMENT OF BIOMOLECULAR SCIENCES
Body Weight (g) Blood Glucose (mg/dL) Heart Weight (g)
Non-diabetic (n=47) 29.05 + 0.37 204.7 + 7.30 0.1173 + 0.005
Diabetic (n=28) 51.09 + 1.26 **** 525.0 + 22.67 **** 0.1106 + 0.002
Non-diabetic RKO (n=41) 32.32 + 0.43 *** 213.3 + 4.58 0.1184 + 0.002
Diabetic RKO (n=12) 56.61 + 0.70 **** 412.7 + 29.44 **** 0.1216 + 0.002
Rap1a WT (n=34) 27.72 + 0.35 217.2 + 6.32 0.1106 + 0.002
Rap1a KO (n=16) 27.61 + 0.74 172.1 + 6.73 0.1085 + 0.005
Migration Assay& Analysis: Used a 48 well 
plate with 2-3 replicates per treatment
Statistical Analysis: A Student’s t-test, one-way ANOVA, or a two-way ANOVA were 
conducted, and ANOVAs were followed by an appropriate post hoc. 
Figure 1: The presence of RAGE signaling negatively impacts cardiac 
fibroblast migration. Cardiac fibroblasts were isolated from (A ) non-diabetic 
with and without RAGE mice, (B) diabetic with and without RAGE mice, and (C) 
Rap1a wildtype (WT) and knockout (KO) mice. (D-F) Fibroblasts were plated onto 
plastic cell culture dishes, scratched (0hr) and assessed for cell migration after 24 
hours. Cells were stained with Coomassie for visualization with the red lines 
depicting scratched area (40X and scale bar = 200µm). Number of migrated cells 
were normalized to percent scratched area and plotted as mean + SEM (n=7-13). 
Student’s t-test used to determine significance.
Figure 2: Collagen isolated from diabetic mouse tails have significantly more 
CMLs and AGEs compared to non-diabetic collagen. A) Immunofluorescence 
(100X; scale bar = 50 µm) images for carboxymethyl lysine (CML) and advanced 
glycation end products (AGEs) in non-diabetic collagen and diabetic collagen. B) 
Graph depicting semi-quantification of CML and AGEs present in non-diabetic and 
diabetic collagen. A two-way ANOVA followed by a Bonferroni post hoc was used 
to determine significance (*p<0.05, ***p<0.001, ****p<0.0001).. 
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Figure 3: The elevated levels of AGEs in diabetic collagen did not significantly 
impact fibroblast migration. Cardiac fibroblasts isolated from A) non-diabetic and 
diabetic, B) non-diabetic and diabetic RAGE knockout, and C) Rap1a WT and KO 
mice were plated on either no collagen (results shown in figure 1), non-diabetic 
collagen, or diabetic collagen. The number of migrated cells were normalized to 
percent scratch area. Data are mean + SEM with a two-way ANOVA and a Sidak’s 
post hoc, n = 10-13 (*p<0.05, **p<0.01, ***p<0.001, ****p<0.0001).  
Figure 4: Cardiac fibroblasts display 
increased migration with decreased 
RAGE signaling on diabetic collagen. 
A) Non-diabetic, B) diabetic, C) non-
diabetic RKO, D) diabetic RKO, E) 
Rap1a WT, and F) Rap1a KO cardiac 
fibroblasts plated on diabetic collagen 
were treated with U0126 (ERK inhibitor; 
5µM) and ps PKC-ζ (pseudosubstrate
PKC-ζ inhibitor; 1µg/mL). Inhibition of 
AGE/RAGE signaling, in RAGE signaling 
competent fibroblasts, led to an increase 
in migration. No changes in migration 
were noted in RKO fibroblasts which 
indicated PKC and ERK inhibition does 
not impact migration independently of 
RAGE signaling. Data represents mean 
+ SEM with a n = 10-13 for control and n 
= 3-9 for treatments. A one-way ANOVA 
and a Dunnett’s post hoc determined 
significance (* p<0.05, ** p<0.01, 
***p<0.001).
Figure 5: Increased exogenous AGEs in diabetic collagen led to increased fibroblast migration. 
Cardiac fibroblasts from A) non-diabetic and diabetic, B) RAGE knockout, and C) Rap1a mice were 
plated on diabetic collagen. Fibroblasts were either untreated (control) or treated with AGEs (0.5 
mg/mL). The increased migration with AGE treatment is possibly an indirect effect. The AGE treatment 
may have caused an increase in “active” fibroblasts, which characteristically migrate more. Cell 
migration was normalized to percent scratch area with mean + SEM being depicted on graph. Two-
way ANOVA with Sidak’s post hoc determined significance (** p<0.01, n = 5-10).
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